TSX gains after CPI shows US inflation rose 3%
Investing.com - UBS raised its price target on 3M (NYSE:MMM) to $190.00 from $184.00 while maintaining a Buy rating following the company’s third-quarter results. The stock, currently trading at $166.64, has gained nearly 20% year-to-date. According to InvestingPro data, analyst targets for 3M range from $101 to $188, with the company maintaining a "Fair" overall financial health score.
The firm cited 3M’s accelerating organic growth, which reached 3.2% year over year in the quarter, exceeding expectations by more than 50 basis points. This performance prompted 3M to raise its full-year organic growth guidance. The $88.76 billion market cap company maintains a solid dividend yield of 1.91%, with a consistent dividend growth track record.
UBS noted that 3M has been "playing defense on the growth narrative for a while," making the third-quarter results "an important proof point for the company’s several initiatives to reinvigorate growth."
The company’s largest segment, Safety and Industrial, showed particularly strong performance with organic growth of 4.1% during the quarter.
UBS also highlighted operational improvements, noting that 3M’s on-time and in-full delivery metrics reached 87%, up from the low 80s during the same period last year.
In other recent news, 3M Company reported a strong performance for the third quarter of 2025, with improvements in both sales and operating margins. The company achieved an earnings per share (EPS) of $2.19, reflecting a 10% increase from the previous year, and raised its full-year EPS guidance to a range of $7.95 to $8.05. Organic sales grew by 3.2%, marking the fourth consecutive quarter of positive growth. RBC Capital responded by raising its price target for 3M from $120 to $130, citing stronger organic growth and progress on new product introductions. Despite maintaining an Underperform rating, RBC noted a "modest/broad-based" operating beat for the quarter. Meanwhile, Morgan Stanley upgraded 3M’s stock from Underweight to Equalweight, increasing its price target to $160. The upgrade reflects a more positive outlook based on lowered growth expectations and emerging self-help initiatives. These recent developments provide investors with a range of perspectives on 3M’s current trajectory.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.